<DOC>
	<DOCNO>NCT01712009</DOCNO>
	<brief_summary>The primary objective study estimate difference bone pain breast cancer patient receive chemotherapy pegfilgrastim either prophylactic intervention , prophylactic naproxen , prophylactic loratadine .</brief_summary>
	<brief_title>NOLAN : Naproxen Loratadine Neulasta</brief_title>
	<detailed_description>In study , investigational product naproxen , non-steroidal antiinflammatory drug ( NSAID ) , loratadine , anti-histamine . Both agent investigate prophylactic medication reduce incidence and/or severity bone pain breast cancer patient receive adjuvant neoadjuvant myelosuppressive chemotherapy pegfilgrastim prophylaxis . Pegfilgrastim treatment use stimulate bone marrow produce neutrophil help fight infection patient undergo chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Age 18 year Eastern cooperative oncology group ( ECOG ) performance status 02 Female newly diagnose , previously treat chemotherapy , stage IIII breast cancer Medically eligible safely receive adjuvant neoadjuvant chemotherapy , pegfilgrastim , naproxen loratadine determine investigator Creatinine â‰¤ 1.5 X upper limit normal ( ULN ) Planning receive least 4 cycle adjuvant neoadjuvant chemotherapy Planning receive prophylaxis pegfilgrastim start first cycle continue throughout chemotherapy cycle treatment period Subject provide informed consent Exclusion Criteria History malignancy within past 5 year , follow exception : Adequately treat nonmelanoma skin cancer lentigo maligna without evidence disease Adequately treat cervical carcinoma situ without evidence disease Planning receive weekly chemotherapy Ongoing chronic pain , painful condition require treatment ( include immediate postoperative treatment surgical proceduralassociated pain ) determine investigator Chronic oral steroid use . Premedication related administration chemotherapy , use antiemetic allow , per usual clinical practice Chronic use oral nonsteroidal antiinflammatory drug ( NSAIDs ) oral antihistamine outside dictate randomization group outline protocol , follow exception : Chronic oral aspirin use cardiovascularrelated indication Prior chemotherapy treatment cancer within 5 year current breast cancer diagnosis Prior use granulocyte colony stimulate factor ( GCSF ) History clinically significant gastrointestinal ( GI ) bleeding , history GI ulcer active GI bleeding within 6 month prior randomization History clinically significant bleeding disorder , thromboembolism within 6 month prior randomization Currently enrol , less 30 day since end , another clinical trial include language direct GCSF ( filgrastim , pegfilgrastim , ) granulocytemacrophage colonystimulating factor ( GMCSF ) ( sargramostim ) use Currently enrol , less 30 day since end , another interventional clinical trial include blind treatment blind treatment arm ( whether subject randomize blinded arm ) Currently enrol , less 30 day since end , another interventional clinical trial include use agent currently consider standard therapy adjuvant neoadjuvant treatment stage IIII breast cancer base National Comprehensive Cancer Network ( NCCN ) Clinical Practice Guidelines Oncology Breast Cancer Currently enrol , less 30 day since end , pain intervention study Female subject pregnant lactate reproductive potential willing employ effective method birth control treatment 17 day discontinue study treatment History evidence clinically significant disorder , condition disease ( exception outline ) , opinion Investigator Amgen , consult , would pose risk subject safety interfere study evaluation , procedure completion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Neulasta</keyword>
	<keyword>Pegfilgrastim</keyword>
	<keyword>Naproxen</keyword>
	<keyword>Loratadine</keyword>
	<keyword>Non-steroidal antiinflammatory drug ( NSAID )</keyword>
	<keyword>Anti-histamine</keyword>
	<keyword>Bone Pain</keyword>
</DOC>